Diagnostic performance of DLS-SWAN improves detection of microbleeds in Alzheimer patients, suggesting rapid screening benefits.
Motivation: While T2* weighted imaging evaluates microbleeds, high-resolution 3D SWI requires long acquisition times with motion artifact risks. Fast imaging is needed for monitoring ARIA-H in Alzheimer's treatment. Goal(s): To evaluate the diagnostic performance of DL Speed (DLS), a vendor-supplied prototype version of Sonic DL, which enables high acceleration rates and short scan times, in detecting microbleeds using DLS-reconstructed 3D SWAN. Approach: 71 cognitive decline patients underwent T2*WI and 2mm DLS-SWAN. Two neuroradiologists conducted readings with and without DLS-SWAN. Results: 2mm DLS-SWAN achieved whole-brain imaging with high resolution in less than 2 minutes, resulting in detection of significantly more definite microbleeds than T2*WI. Impact: DLS-SWAN can potentially be useful as a rapid 3D T2* technique for screening MRI at baseline in patients undergoing monoclonal antibody therapy for Alzheimer disease.
No takes yet. Share an insight, caveat, or question.
Ishimoto et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: